Exosomes play roles in sequential processes of tumor metastasis

International Journal of Cancer. Journal International Du Cancer
Keyu LiXubao Liu

Abstract

Overwhelming evidence demonstrates that exosomes, a series of biologically functional small vesicles of endocytic origin carrying a variety of active constituents, especially tumor-derived exosomes, contribute to tumor progression and metastasis. This review focuses on the specific multifaceted roles of exosomes in affecting sequenced four crucial processes of metastasis, through which cancer cells spread from primary to secondary organs and finally form macroscopic metastatic lesions. First, exosomes modulate the primary tumor sites to assist cancer growth and dissemination. In this part, five main biological events are reviewed, including the transfer of oncogenic constituents, the recruitment and activation of fibroblasts, the induction of angiogenesis, immunosuppression and epithelial-mesenchymal transition (EMT) promotion. In Step 2, we list two recently disclosed mechanisms during the organ-specific homing process: the exosomal integrin model and exosomal epidermal growth factor receptor (EGFR)/miR-26/hepatocyte growth factor (HGF) model. Subsequently, Step 3 focuses on the interactions between exosomes and pre-metastatic niche, in which we highlight the specific functions of exosomes in angiogenesis, lymphangiogenesis, i...Continue Reading

References

Jun 15, 2007·Journal of Mammary Gland Biology and Neoplasia·Xin Lu, Yibin Kang
Feb 25, 2009·International Journal of Cancer. Journal International Du Cancer·Xiaoyu XiangHuang-Ge Zhang
Mar 25, 2009·Nature Reviews. Cancer·Bethan Psaila, David Lyden
Jun 6, 2009·Nature Reviews. Immunology·Clotilde ThéryElodie Segura
Oct 6, 2009·The Journal of Biological Chemistry·Isabella ParoliniStefano Fais
Oct 7, 2009·Thrombosis and Haemostasis·William L DeanDavid W Powell
Sep 15, 2010·The Journal of Cell Biology·Arthit ChairoungduaMichael J Caplan
Jan 25, 2011·Nature Reviews. Cancer·Laurie J Gay, Brunhilde Felding-Habermann
Feb 5, 2011·Cancer Immunology, Immunotherapy : CII·Christina BattkeReinhard Zeidler
Mar 2, 2011·The American Journal of Pathology·Gregoire MignotFrançois Ghiringhelli
Apr 12, 2011·Cancer Research·Joshua L HoodSamuel A Wickline
May 11, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhijian CaiJianli Wang
Jun 23, 2012·Pharmacological Reviews·Edwin van der PolRienk Nieuwland
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·Muller FabbriCarlo M Croce
Apr 17, 2013·Proceedings of the National Academy of Sciences of the United States of America·Paulina KucharzewskaMattias Belting
May 3, 2013·Cancer Metastasis Reviews·Jaclyn SceneayAndreas Möller
Jun 5, 2013·International Journal of Clinical Oncology·Yoshihiro NishidaNaoki Ishiguro
Aug 3, 2013·Neoplasia : an International Journal for Oncology Research·Wei MuMargot Zöller
Sep 7, 2013·Journal of Extracellular Vesicles·Stephen J Gould, Graça Raposo
Sep 21, 2013·Nature·Melissa R Junttila, Frederic J de Sauvage
Nov 10, 2013·Nature Medicine·Daniela F Quail, Johanna A Joyce
Apr 17, 2014·Cancer Cell·Weiying ZhouShizhen Emily Wang
Jul 16, 2014·Seminars in Oncology·Nick van EsRienk Nieuwland
Oct 8, 2014·Annual Review of Cell and Developmental Biology·Marina ColomboClotilde Théry
Jan 8, 2015·Frontiers in Oncology·Laura Jayne Vella
Mar 1, 2015·Seminars in Cell & Developmental Biology·David W GreeningWeisan Chen
May 20, 2015·Nature Cell Biology·Bruno Costa-SilvaDavid Lyden

❮ Previous
Next ❯

Citations

Mar 16, 2019·FEBS Letters·Yinan LiYuanyan Wei
May 10, 2019·Cell Death & Disease·H JingJ Zhou
May 19, 2020·Journal of Clinical Laboratory Analysis·Yezhao WangJunming Guo
Jul 11, 2020·Cancers·Grace L WongHui-Wen Lo
Aug 15, 2019·Molecular Cancer·Wenlong FengZhenfeng Duan
Jul 29, 2020·Cell Death & Disease·Ethan Z Malkin, Scott V Bratman
Feb 2, 2019·World Journal of Clinical Cases·Chi-Hin Wong, Yang-Chao Chen
Feb 23, 2019·Frontiers in Immunology·Yungang WangShengjun Wang
Jun 21, 2019·International Journal of Molecular Sciences·Loredana AlboniciRoberto Bei
Apr 14, 2019·Proteomes·Stephanie N Hurwitz, David G Meckes
Jul 14, 2019·Cellular and Molecular Life Sciences : CMLS·Changbiao Li, Xiao Xu
Apr 18, 2020·Journal of Experimental & Clinical Cancer Research : CR·Shiming TanQianjin Liao
Sep 30, 2019·Molecular Aspects of Medicine·Stefan WernerKlaus Pantel
Jan 22, 2021·Current Opinion in Genetics & Development·Karoliina StefaniusKim Orth
Feb 12, 2021·Frontiers in Physiology·An-Ran ShenLin-Li Lv
Dec 29, 2020·Frontiers in Cell and Developmental Biology·Naoya KuriyamaTakahiro Ochiya
Jan 6, 2021·Cancers·Houssam AhegetKarim Benabdellah
Feb 26, 2021·Journal of Immunology Research·Sergio Ayala-MarJosé González-Valdez
Mar 12, 2021·Small·Jesús Ruiz-EspigaresJuan Antonio Marchal
Apr 6, 2021·Veterinary Pathology·Laura BongiovanniAlain de Bruin
Jul 24, 2021·Carbohydrate Polymers·Vinoth KrishnanMurugan Veerapandian
Aug 3, 2021·Frontiers in Immunology·Patrick Santos, Fausto Almeida
Aug 25, 2021·Technology in Cancer Research & Treatment·Qian ZhangHuanliang Liu
Oct 16, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Xintong ShenXiaodan Meng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Archivum Immunologiae Et Therapiae Experimentalis
Amin Pastaki KhoshbinNima Rezaei
Biochimica Et Biophysica Acta
Thomas R Geiger, Daniel S Peeper
© 2022 Meta ULC. All rights reserved